| Name | Title | Contact Details |
|---|---|---|
Kim Barratt |
Chief Talent Officer | Profile |
Noxxon Pharma AG is a Germany-based biotechnology company with focus on cancer treatment. The Company develops drugs under the trademark Spiegelmer, which target the tumor microenvironment. Spiegelmers can be manufactured chemically and are a variant o...
Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, leveraging technology from the lab of Nobel laureate Dr. Paul Greengard, for the treatment of neuropsychiatric and neurodegenerative diseases. The Company is developing its lead drug candidate, lumateperone, a first-in-class molecule, which is in Phase 3 clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia, including Alzheimer`s disease. The Company is also utilizing its phosphodiesterase (PDE) platform and other proprietary chemistry platforms to develop drugs for the treatment of CNS and other disorders. The lead compound in the PDE platform, ITI-214, a PDE1 inhibitor is being developed for the treatment of CNS and non-CNS indications.
Tetragenex Pharmaceuticals is a Syosset, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SpaLab, Inc. is a San Marcos, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Nutraceutics Corp is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.